companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

MDS METRO LABORATORY SERVICES

GIBSONS-Canada

Company Name:
Corporate Name:
MDS METRO LABORATORY SERVICES
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 821 Highway 101,GIBSONS,BC,Canada 
ZIP Code:
Postal Code:
V0N 
Telephone Number: 6048868841 
Fax Number:  
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
130490 
USA SIC Description:
LABORATORIES 
Number of Employees:
 
Sales Amount:
 
Credit History:
Credit Report:
 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
METZ APPLIANCE SALES & SVC
MEDICAL CLINIC
MDS METRO LABORATORY SVC
Next company profile:
MCFARLAND JAMES DR INC
MCDONALDS RESTAURANTS
MC FARLAND, JAMES MD










Company News:
  • Myelodysplastic syndromes - Symptoms and causes - Mayo Clinic
    Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly formed or don't work properly Myelodysplastic syndromes result from something amiss in the spongy material inside your bones where blood cells are made (bone marrow)
  • What Are Myelodysplastic Syndromes (MDS)? - American Cancer Society
    Myelodysplastic syndromes (MDS), also known as myelodysplastic neoplasms, are conditions that can occur when the blood-forming cells in the bone marrow become abnormal, resulting in the marrow not making enough healthy new blood cells This leads to low levels of one or more types of blood cells MDS is considered a type of cancer
  • Myelodysplastic Syndrome (MDS): Symptoms, Diagnosis Treatment
    Myelodysplastic syndrome (also called myelodysplasia or MDS) affects blood stem cells People with MDS don’t have enough healthy blood cells MDS can cause anemia, frequent infections and bleeding that won’t stop Some people with MDS develop acute myeloid leukemia MDS treatment focuses on keeping it from getting worse
  • Myelodysplastic Syndromes (MDS): Causes, Symptoms, Treatment - WebMD
    What Are Myelodysplastic Syndromes? Myelodysplastic syndromes (MDS) are a rare group of disorders in which your body no longer makes enough healthy blood cells With MDS, your bone
  • Myelodysplastic Syndrome | MD Anderson Cancer Center
    Myelodysplastic syndrome is a group of diseases in which the bone marrow doesn’t produce enough healthy blood cells Instead, it makes too many immature cells, called blasts These blasts die in the marrow or soon after entering the bloodstream, resulting in too few healthy blood cells and low blood counts
  • Myelodysplastic Syndromes Treatment - NCI - National Cancer Institute
    Myelodysplastic syndromes are a group of cancers in which immature blood cells in the bone marrow do not mature or become healthy blood cells The different types of myelodysplastic syndromes are diagnosed based on certain changes in the blood cells and bone marrow
  • What Is Myelodysplastic Syndrome (MDS) | OSUCCC – James
    Myelodysplastic Syndrome, or MDS, is a rare blood disorder that develops when the bone marrow is unable to produce normal, healthy blood cells Learn more
  • Diagnosis and classification of myelodysplastic syndromes
    Myelodysplastic syndromes (MDSs) are myeloid neoplasms characterized by morphologically abnormal and ineffective maturing hematopoiesis, resulting in peripheral blood cytopenias
  • Treatment Goals in Newly Diagnosed Lower-Risk MDS: Key Clinical and . . .
    A panelist discusses the evolving role of luspatercept in low-risk myelodysplastic syndrome, highlighting its broad efficacy beyond SF3B1 mutations, its advantage in reducing transfusions and improving quality of life, and the shift toward treatment decisions based on clinical presentation and lifestyle factors rather than genetic profiles alone




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer